PL355664A1 - Trwałe preparaty galenowe zawierające benzimidazol i sposób ich wytwarzania - Google Patents

Trwałe preparaty galenowe zawierające benzimidazol i sposób ich wytwarzania

Info

Publication number
PL355664A1
PL355664A1 PL00355664A PL35566400A PL355664A1 PL 355664 A1 PL355664 A1 PL 355664A1 PL 00355664 A PL00355664 A PL 00355664A PL 35566400 A PL35566400 A PL 35566400A PL 355664 A1 PL355664 A1 PL 355664A1
Authority
PL
Poland
Prior art keywords
production
benzimidazol
galenic preparations
stable galenic
stable
Prior art date
Application number
PL00355664A
Other languages
English (en)
Other versions
PL202498B1 (pl
Inventor
Benoit Schmitt
Original Assignee
Ratiopharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7932028&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL355664(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ratiopharm Gmbh filed Critical Ratiopharm Gmbh
Publication of PL355664A1 publication Critical patent/PL355664A1/pl
Publication of PL202498B1 publication Critical patent/PL202498B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
PL355664A 1999-12-09 2000-12-06 Doustny środek leczniczy w postaci granulek zawierający związek benzimidazolu i sposób jego wytwarzania PL202498B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19959419A DE19959419A1 (de) 1999-12-09 1999-12-09 Stabile galenische Zubereitungen umfassend ein Benzimidazol und Verfahren zu ihrer Herstellung
PCT/EP2000/012286 WO2001041734A2 (de) 1999-12-09 2000-12-06 Stabile galenische zubereitungen umfassend ein benzimidazol und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
PL355664A1 true PL355664A1 (pl) 2004-05-04
PL202498B1 PL202498B1 (pl) 2009-06-30

Family

ID=7932028

Family Applications (1)

Application Number Title Priority Date Filing Date
PL355664A PL202498B1 (pl) 1999-12-09 2000-12-06 Doustny środek leczniczy w postaci granulek zawierający związek benzimidazolu i sposób jego wytwarzania

Country Status (20)

Country Link
US (1) US7105180B2 (pl)
EP (1) EP1235555B1 (pl)
JP (1) JP2003516342A (pl)
AT (1) ATE267005T1 (pl)
AU (1) AU776384B2 (pl)
CA (1) CA2393483C (pl)
CZ (1) CZ295266B6 (pl)
DE (2) DE19959419A1 (pl)
DK (1) DK1235555T3 (pl)
ES (1) ES2217025T3 (pl)
HK (1) HK1046364B (pl)
HU (1) HUP0203310A3 (pl)
NO (1) NO20022260L (pl)
PL (1) PL202498B1 (pl)
PT (1) PT1235555E (pl)
RU (1) RU2257885C2 (pl)
SK (1) SK284239B6 (pl)
TR (1) TR200401304T4 (pl)
WO (1) WO2001041734A2 (pl)
ZA (1) ZA200204536B (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2299710T3 (es) * 2002-08-02 2008-06-01 Ratiopharm Gmbh Preparacion farmaceutica que contiene un compuesto de bencimidazol mezclado con celulosa microcristalina y un metodo para su preparacion.
US20050214371A1 (en) * 2004-03-03 2005-09-29 Simona Di Capua Stable pharmaceutical composition comprising an acid labile drug
US20060024362A1 (en) * 2004-07-29 2006-02-02 Pawan Seth Composition comprising a benzimidazole and process for its manufacture
WO2013122554A1 (en) 2012-02-14 2013-08-22 Mahmut Bilgic Pellet formulations comprising esomeprazole
CA2910865C (en) 2014-07-15 2016-11-29 Isa Odidi Compositions and methods for reducing overdose
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
AU2023369990A1 (en) 2022-10-20 2025-03-13 Hermes Pharma Gmbh Talc-free active ingredient coating

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB646006A (en) 1944-08-19 1950-11-15 Amalgamated Wireless Australas Improved short circuiting piston devices for waveguides
GB1190387A (en) 1966-05-24 1970-05-06 Green Cross Corp Enteric Coated Medicaments
JPS4819231B1 (pl) * 1970-03-06 1973-06-12
ZA743391B (en) 1974-05-28 1975-08-27 A Warren Therapeutic products
DE2732335C2 (de) 1976-07-27 1983-01-20 Sandoz-Patent-GmbH, 7850 Lörrach Tablette zur enteralen Verabreichung von Indolyloxyalkanolamin-Derivaten
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4370313A (en) * 1981-10-26 1983-01-25 Eaton Laboratories, Inc. Nitrofurantoin dosage form
DE3151196A1 (de) 1981-12-23 1983-06-30 Kurt Heinz Prof. Dr. 7800 Freiburg Bauer Verfahren zur herstellung von gut loeslichen 5-aminosalicylsaeure-arzneimittelzubereitungen
JPS58109413A (ja) 1981-12-23 1983-06-29 Eisai Co Ltd 耐衝撃性腸溶錠
JPS5920219A (ja) 1982-07-26 1984-02-01 Shin Etsu Chem Co Ltd 腸溶性コ−テイング製剤の製造方法
DE3233764C2 (de) 1982-09-11 1987-05-07 R.P. Scherer GmbH, 6930 Eberbach Verfahren zur Herstellung oraler Dosierungseinheiten
SE8301182D0 (sv) 1983-03-04 1983-03-04 Haessle Ab Novel compounds
JPS59193831A (ja) 1983-04-18 1984-11-02 Sankyo Co Ltd 腸溶性製剤の製造法
CA1327010C (en) 1986-02-13 1994-02-15 Tadashi Makino Stabilized solid pharmaceutical composition containing antiulcer benzimidazole compound and its production
GB2189699A (en) 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
JPH0768125B2 (ja) 1988-05-18 1995-07-26 エーザイ株式会社 酸不安定化合物の内服用製剤
US5232706A (en) * 1990-12-31 1993-08-03 Esteve Quimica, S.A. Oral pharmaceutical preparation containing omeprazol
YU48263B (sh) * 1991-06-17 1997-09-30 Byk Gulden Lomberg Chemische Fabrik Gmbh. Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola
DE69127275T2 (de) * 1991-06-21 1998-03-12 Ilsan Ilac Ve Hammaddeleri San Neues galenisches Verfahren für Omeprazol enthaltende Pellets
FR2692146B1 (fr) 1992-06-16 1995-06-02 Ethypharm Sa Compositions stables de microgranules d'omeprazole gastro-protégés et leur procédé d'obtention.
SE9302396D0 (sv) * 1993-07-09 1993-07-09 Ab Astra A novel compound form
ES2094694B1 (es) * 1995-02-01 1997-12-16 Esteve Quimica Sa Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion.
CH687810A5 (de) 1995-05-24 1997-02-28 Mepha Ag Pelletformulierung mit Omeprazol.
JP3833314B2 (ja) * 1995-09-08 2006-10-11 武田薬品工業株式会社 発泡性組成物およびその製造方法
PT101826A (pt) 1996-02-06 1997-09-30 Medinfar Produtos Farmaceutico Processo para a preparacao de microgranulos contendo omeprazole
WO1998019668A1 (en) 1996-11-06 1998-05-14 Sharmatek, Inc. Delayed delivery system for acid-sensitive drugs
CA2282513C (en) 1997-03-13 2007-09-18 Hexal Ag Stabilization of acid sensitive benzimidazoles with amino acid/cyclodextrin combinations
GB9710800D0 (en) * 1997-05-23 1997-07-23 Cipla Limited Pharmaceutical composition and method of preparing it
DK173431B1 (da) * 1998-03-20 2000-10-23 Gea Farmaceutisk Fabrik As Farmaceutisk formulering omfattende en 2-[[(2-pyridinyl)methyl]sulfinyl]benzimidazol med anti-ulcusaktivitet samt fremgangs

Also Published As

Publication number Publication date
EP1235555B1 (de) 2004-05-19
ZA200204536B (en) 2003-09-29
SK7802002A3 (en) 2003-01-09
DE50006531D1 (de) 2004-06-24
CZ20021875A3 (cs) 2002-11-13
AU2672001A (en) 2001-06-18
PL202498B1 (pl) 2009-06-30
RU2002114862A (ru) 2004-01-27
AU776384B2 (en) 2004-09-09
CA2393483A1 (en) 2001-06-14
HK1046364A1 (en) 2003-01-10
TR200401304T4 (tr) 2004-09-21
NO20022260D0 (no) 2002-05-10
PT1235555E (pt) 2004-09-30
ATE267005T1 (de) 2004-06-15
NO20022260L (no) 2002-05-10
WO2001041734A2 (de) 2001-06-14
US20030114494A1 (en) 2003-06-19
SK284239B6 (en) 2004-11-03
DK1235555T3 (da) 2004-07-26
ES2217025T3 (es) 2004-11-01
JP2003516342A (ja) 2003-05-13
US7105180B2 (en) 2006-09-12
EP1235555A2 (de) 2002-09-04
HUP0203310A3 (en) 2004-01-28
CZ295266B6 (cs) 2005-06-15
DE19959419A1 (de) 2001-06-21
CA2393483C (en) 2009-09-15
HUP0203310A2 (hu) 2003-02-28
RU2257885C2 (ru) 2005-08-10
HK1046364B (zh) 2004-10-21
WO2001041734A3 (de) 2001-12-06

Similar Documents

Publication Publication Date Title
IL131651A0 (en) A pharmaceutical formulation containing benzimidazoles with amino acid/caclodextrin combinations and a process for producing the same
WO2002008199A3 (en) Efficient ligand-mediated ullmann coupling of anilines and azoles
AU2002354739A1 (en) Process for the production of optically active 3-phenylisoserine
AU2001294228A1 (en) Benzimidazole compounds, process for producing the same and use thereof
PL375103A1 (pl) Związek typu 1-podstawionego-4-nitroimidazolu i sposób jego wytwarzania
AU2001263835A1 (en) Haemostatically active preparation containing vWF and method for the production thereof
WO2001030330A3 (en) Method to treat pain utilizing benzimidazole nmda/nr2b antagonists
AU6442900A (en) Aminocarbonyl-substituted benzimidazole derivatives, method for producing same and the use thereof as medicaments
DE50003566D1 (de) Haftvermittler
CA2393483A1 (en) Stable pharmaceutical preparations comprising a benzimidazole and process for their production
CA2362217A1 (en) Process for preparing phenylpyrazole pesticidal intermediates
ZA200107985B (en) Substituted benzimidazole, the production thereof and the use thereof as means against parasitic protozoa.
ZA200500918B (en) 1-substituted 4-nitroimidazole compound and process for producing the same
IL148161A0 (en) Process for the preparation of 2-cyanopyridines
IL144809A0 (en) Method for the production of aliphatic fluoroformates
PL356523A1 (pl) Podstawione 1-i 2-naftolowe zasady Mannicha
AU4758400A (en) Method for the production of polyamides
AU3606100A (en) Methods for administering pharmacologically active compounds to vertebrates
CA2366820A1 (fr) Nouveaux derives de [(2-substitue-5 -[3-thienyl]) -benzyl]-[2- ([2-isopropoxy-5-fluoro] -phenoxy) -ethyl] -amine, leur procede de preparation et leur utilisation a titre de medicaments
ITTO20000965A0 (it) Procedimento per produrre l'acido monocarbossilico + )-trans-crisantemico.
AU2010203141B2 (en) Apparatus for delivery of pharmaceuticals to the cochlea
AU6837300A (en) Method for the production of phosphonomethylglycine
HUP0203463A3 (en) Bis(1-aziridino-1-hydroxyiminomethyl)-derivatives, method for the production thereof and use thereof as anti-tumoral agents
AU1864601A (en) Penicillin production using transgenic merodiploid strains
AU7905500A (en) Aryl-sulfonamide substituted benzimidazol derivatives and use of said as tryptase inhibitors

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20101206